Deficiency in neuronal TGF-beta signaling promotes neurodegeneration and Alzheimer's pathology.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Journal of Clinical Investigation

• Publication date

  2006-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1172/JCI27341PMID 17080199PMCID PMC1626127
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database

  2007cited by this paper
• Phagocytosis and Deposition of Vascular -amyloid in Rat Brains Injected with Alzheimer -amyloid

  2007cited by this paper
• Increased App expression in a mouse model of Down's syndrome disrupts NGF transport and causes cholinergic neuron degeneration.

  2006cited by this paper
• Mapping scores onto stages: mini-mental state examination and clinical dementia rating.

  2006cited by this paper
• Neurotrophins and dementia--keeping in touch.

  2006cited by this paper
• SPECIFICITY AND VERSATILITY IN TGF-β SIGNALING THROUGH SMADS

  2005cited by this paper
• Inducible neuronal expression of transgenic TGF‐β1 in vivo: dissection of short‐term and long‐term effects

  2005cited by this paper
• Specificity and versatility in tgf-beta signaling through Smads.

  2005cited by this paper
• Fyn Kinase Induces Synaptic and Cognitive Impairments in a Transgenic Mouse Model of Alzheimer's Disease

  2005cited by this paper
• Reduction of cortical TrkA but not p75NTR protein in early‐stage Alzheimer's disease

  2004cited by this paper
• Intracellularly generated amyloid‐β peptide counteracts the antiapoptotic function of its precursor protein and primes proapoptotic pathways for activation by other insults in neuroblastoma cells

  2004influential reference
• Retrograde Regulation in the CNS: Neuron-Specific Interpretations of TGF-β Signaling

  2004cited by this paper
• SB-505124 is a selective inhibitor of transforming growth factor-beta type I receptors ALK4, ALK5, and ALK7.

  2004cited by this paper
• Amyloid-beta: a chameleon walking in two worlds: a review of the trophic and toxic properties of amyloid-beta.

  2003cited by this paper
• The tissue plasminogen activator-plasminogen proteolytic cascade accelerates amyloid-beta (Abeta) degradation and inhibits Abeta-induced neurodegeneration.

  2003cited by this paper
• TGF-ßS and Their Roles in the Regulation of Neuron Survival

  2003cited by this paper
• Amyloid-β: a chameleon walking in two worlds: a review of the trophic and toxic properties of amyloid-β

  2003cited by this paper
• Insulin-degrading enzyme regulates the levels of insulin, amyloid β-protein, and the β-amyloid precursor protein intracellular domain in vivo

  2003cited by this paper
• Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo.

  2003influential reference
• Alzheimer's Disease β-Amyloid Peptide Is Increased in Mice Deficient in Endothelin-converting Enzyme*

  2003cited by this paper
• The Tissue Plasminogen Activator-Plasminogen Proteolytic Cascade Accelerates Amyloid-β (Aβ) Degradation and Inhibits Aβ-Induced Neurodegeneration

  2003cited by this paper
• Cerebrovascular transforming growth factor-beta contributes to inflammation in the Alzheimer's disease brain.

  2002cited by this paper
• Transforming growth factor signal transduction

  2002cited by this paper
• Decrease of TGF-beta1 plasma levels and increase of nitric oxide synthase activity in leukocytes as potential biomarkers of Alzheimer's disease.

  2002cited by this paper
• Astrocytes Are Less Efficient in the Removal of Apoptotic Lymphocytes than Microglia Cells: Implications for the Role of Glial Cells in the Inflamed Central Nervous System

  2002cited by this paper
• TGF-betas and their roles in the regulation of neuron survival.

  2002cited by this paper
• Protein Kinase Modulation of a Neuronal Cation Channel Requires Protein–Protein Interactions Mediated by an Src homology 3 Domain

  2002cited by this paper
• Decrease of TGF-β1 plasma levels and increase of nitric oxide synthase activity in leukocytes as potential biomarkers of Alzheimer's disease

  2002cited by this paper
• Transforming Growth Factor β1 Alters Synapsin Distribution and Modulates Synaptic Depression inAplysia

  2002cited by this paper
• Alzheimer's disease: genes, proteins, and therapy.

  2001cited by this paper
• Brain-derived neurotrophic factor in the control human brain, and in Alzheimer's disease and Parkinson's disease.

  2001cited by this paper
• Type III TGF‐β receptor‐independent signalling of TGF‐β2 via TβRII‐B, an alternatively spliced TGF‐β type II receptor

  2001cited by this paper
• Metabolic Regulation of Brain Aβ by Neprilysin

  2001cited by this paper
• Metabolic regulation of brain Abeta by neprilysin.

  2001influential reference
• Type III TGF-beta receptor-independent signalling of TGF-beta2 via TbetaRII-B, an alternatively spliced TGF-beta type II receptor.

  2001cited by this paper
• TGF-beta1 promotes microglial amyloid-beta clearance and reduces plaque burden in transgenic mice.

  2001cited by this paper
• Cognition and survival: an exploration in a large multicentre study of the population aged 65 years and over.

  2001cited by this paper
• TGF-β1 promotes microglial amyloid-β clearance and reduces plaque burden in transgenic mice

  2001cited by this paper
• Alzheimer-like neurodegeneration in aged antinerve growth factor transgenic mice.

  2000cited by this paper
• High-Level Neuronal Expression of Aβ1–42 in Wild-Type Human Amyloid Protein Precursor Transgenic Mice: Synaptotoxicity without Plaque Formation

  2000cited by this paper
• Cortical degeneration in the absence of neurotrophin signaling: dendritic retraction and neuronal loss after removal of the receptor TrkB.

  2000cited by this paper
• Loss of nucleus basalis neurons containing trkA immunoreactivity in individuals with mild cognitive impairment and early Alzheimer's disease

  2000cited by this paper
• Ligand-induced downregulation of receptors for TGF-beta in human osteoblast-like cells from adult donors.

  1999cited by this paper
• Profound and selective loss of catalytic TrkB immunoreactivity in Alzheimer's disease.

  1999cited by this paper
• Expression of Human Apolipoprotein E3 or E4 in the Brains ofApoe−/− Mice: Isoform-Specific Effects on Neurodegeneration

  1999cited by this paper
• BDNF and full-length and truncated TrkB expression in Alzheimer disease. Implications in therapeutic strategies.

  1999cited by this paper
• The role of neuronal growth factors in neurodegenerative disorders of the human brain.

  1998cited by this paper
• Doxycycline control of prion protein transgene expression modulates prion disease in mice.

  1998influential reference
• TGF-beta receptors-I and -II immunoexpression in Alzheimer's disease: a comparison with aging and progressive supranuclear palsy.

  1998cited by this paper
• Transforming growth factor-betas in neurodegenerative disease.

  1998cited by this paper
• Transforming growth factor-betas in neurodegenerative disease.

  1998cited by this paper
• Direct binding of Smad3 and Smad4 to critical TGFβ‐inducible elements in the promoter of human plasminogen activator inhibitor‐type 1 gene

  1998cited by this paper
• TGF-β receptors-I and -II immunoexpression in Alzheimer’s disease: a comparison with aging and progressive supranuclear palsy

  1998cited by this paper
• Expression of a dominant-negative type II transforming growth factor beta (TGF-beta) receptor in the epidermis of transgenic mice blocks TGF-beta-mediated growth inhibition.

  1997cited by this paper
• Selective phosphorylation of adult tau isoforms in mature hippocampal neurons exposed to fibrillar A beta.

  1997cited by this paper
• Pharmacology of neurotrophic factors.

  1997cited by this paper
• Expression of a dominant-negative mutant TGF-beta type II receptor in transgenic mice reveals essential roles for TGF-beta in regulation of growth and differentiation in the exocrine pancreas.

  1997cited by this paper
• Comparison of Two Quantitative Methods for the Evaluation of Neuronal Number in the Frontal Cortex in Alzheimer Disease

  1997cited by this paper
• Transforming growth factor beta-induced phosphorylation of Smad3 is required for growth inhibition and transcriptional induction in epithelial cells.

  1997influential reference
• Expression of a dominant‐negative mutant TGF‐β type II receptor in transgenic mice reveals essential roles for TGF‐β in regulation of growth and differentiation in the exocrine pancreas

  1997cited by this paper
• Amyloidogenic role of cytokine TGF-β1 in transgenic mice and in Alzheimer's disease

  1997cited by this paper
• Expression of a dominant-negative type II transforming growth factor β (TGF-β) receptor in the epidermis of transgenic mice blocks TGF-β-mediated growth inhibition

  1997cited by this paper
• TrkB and TrkC neurotrophin receptors cooperate in promoting survival of hippocampal and cerebellar granule neurons.

  1996cited by this paper
• Molecular detection of pre‐atl state among healthy HTLV‐1 carriers in an endemic area of Japan

  1995cited by this paper
• Transforming growth factor-beta (TGF-beta)-induced down-regulation of cyclin A expression requires a functional TGF-beta receptor complex. Characterization of chimeric and truncated type I and type II receptors.

  1995cited by this paper
• The soluble exoplasmic domain of the type II transforming growth factor (TGF)-beta receptor. A heterogeneously glycosylated protein with high affinity and selectivity for TGF-beta ligands.

  1995cited by this paper
• Transforming Growth Factor-β (TGF-β)-induced Down-regulation of Cyclin A Expression Requires a Functional TGF-β Receptor Complex

  1995cited by this paper
• Altered expression of transforming growth factor-beta in Alzheimer's disease

  1995cited by this paper
• Targeted disruption of the BDNF gene perturbs brain and sensory neuron development but not motor neuron development.

  1994cited by this paper
• Central nervous system damage produced by expression of the HIV-1 coat protein gp120 in transgenic mice.

  1994cited by this paper
• Phagocytosis and deposition of vascular beta-amyloid in rat brains injected with Alzheimer beta-amyloid.

  1992cited by this paper
• Spectrum of human immunodeficiency virus–associated neocortical damage

  1992cited by this paper
• Tight control of gene expression in mammalian cells by tetracycline-responsive promoters.

  1992cited by this paper
• Three-Dimensional Analysis of the Relationship Between Synaptic Pathology and Neuropil Threads in Alzheimer Disease

  1992cited by this paper
• Identification of regulatory sequences in the type 1 plasminogen activator inhibitor gene responsive to transforming growth factor beta.

  1991cited by this paper
• “Mini-mental state”: A practical method for grading the cognitive state of patients for the clinician

  1975cited by this paper

• Integrated Plasma and Glial Cell Evidence Indicates a Functional Role for hsa-miR-342-5p in Spinocerebellar Ataxia Type 7 and Its Potential Use as a Biomarker

  2026cites this paper
• RNA transcripts in salivary extracellular vesicle cargo isolated from aged populations

  2026cites this paper
• Overexpression of TGFBR3 Aggravates Cognitive Impairment and Neuroinflammation by Promoting Microglia M1 Polarization in the APP/PS1 Mouse Model of Alzheimer's Disease

  2025cites this paper
• The roles of microglia and astrocytes in neuroinflammation of Alzheimer’s disease

  2025cites this paper
• Neuroinflammation in kidney disease and dialysis.

  2025cites this paper
• Association between serum PGRN and cognitive impairment in patients with coronary artery disease: a case-control study.

  2025cites this paper
• Linking expression and function of Drosophila type-I TGF-β receptor baboon isoforms: Multiple roles of BaboA isoform in shaping of the adult central nervous system

  2025cites this paper
• Transcriptomic analysis reveals potential targets associated with hippocampus vulnerability in spatial cognitive dysfunctionof type 2 diabetes mellitus rats.

  2025cites this paper
• Internalization of extracellular Tau oligomers in Alzheimer's disease.

  2025cites this paper
• Mendelian Randomization in Conjunction with WGCNA Was Employed to Investigate the Potential Role of the Liver-Brain Axis in the Pathogenesis of Hepatocellular Carcinoma and Alzheimer’s Disease

  2025cites this paper
• In Search of New Pharmacological Targets: Beyond Carnosine’s Antioxidant, Anti-Inflammatory, and Anti-Aggregation Activities

  2025cites this paper
• When Two Worlds Collide: The Contribution and Association Between Genetics (APOEε4) and Neuroinflammation (IL-1β) in Alzheimer’s Neuropathogenesis

  2025cites this paper
• Study on the Therapeutic Effects of Bisdemethoxycurcumin on a Cerebral Amyloid Angiopathy Mouse Model Established via Chronic Treatment With Five Vascular Risk Factors

  2025cites this paper
• A review of the TGF-β1 pathway in Alzheimer's disease and depression: Possible restoration potential of antidepressants.

  2025cites this paper
• AIMP1: multifunctional regulator in physiology and pathology with therapeutic implications

  2025cites this paper
• Whole Transcriptome RNA-Seq Reveals Drivers of Pathological Dysfunction in a Transgenic Model of Alzheimer’s Disease

  2025cites this paper
• Analytical Review on Normal Brain Aging, Alzheimer’s Disease, and Stage 4S Neuroblastoma: Novel Insights Into Neuroprotection, Neurodegeneration, and Spontaneous Regression

  2025cites this paper
• Border-associated macrophages: From physiology to therapeutic targets in Alzheimer's disease.

  2024cites this paper
• Transcriptomic analysis reveals sex-specific patterns in the hippocampus in Alzheimer’s disease

  2024cites this paper
• Adult microglial TGFβ1 is required for microglia homeostasis via an autocrine mechanism to maintain cognitive function in mice

  2024cites this paper
• Microglial Transforming Growth Factor-β Signaling in Alzheimer’s Disease

  2024influential citation
• Impact of Bruxism in Alzheimer’s Disease

  2024cites this paper
• Viral hepatitis moderates the impact of TGFB1 on neurocognitive impairment

  2024cites this paper
• The role of zinc in the premature brain: functions, outcomes and future research perspectives

  2024cites this paper
• Ageing-related changes in the regulation of microglia and their interaction with neurons.

  2024cites this paper
• Digging into the intrinsic capacity concept: can it be applied to Alzheimer's disease?

  2024cites this paper
• Involvement of inflammasomes in the pathogenesis of Alzheimer's disease

  2024cites this paper
• The intricate interplay between microglia and adult neurogenesis in Alzheimer’s disease

  2024cites this paper
• The dichotomic role of cytokines in aging

  2024cites this paper
• Breaking Barriers in Alzheimer’s Disease: the Role of Advanced Drug Delivery Systems

  2024cites this paper
• MicroRNA-455-3P as a peripheral biomarker and Therapeutic Target for Mild Cognitive Impairment and Alzheimer's disease.

  2024cites this paper
• Intergenerational epigenetic inheritance mediated by MYS-2/MOF in the pathogenesis of Alzheimer’s disease

  2024cites this paper
• Tracking neuroinflammatory biomarkers in Alzheimer’s disease: a strategy for individualized therapeutic approaches?

  2024cites this paper
• Soluble TGF‐β decoy receptor TGFBR3 exacerbates Alzheimer's disease pathology by modifying microglial function

  2024cites this paper
• Mediterranean Diet Modulation of Neuroinflammation-Related Genes in Elderly Adults at High Cardiovascular Risk

  2024cites this paper
• Aging Microglia and Their Impact in the Nervous System.

  2024cites this paper
• The role of genetics and gender specific differences in neurodegenerative disorders: Insights from molecular and immune landscape.

  2023cites this paper
• Perivascular cells induce microglial phagocytic states and synaptic engulfment via SPP1 in mouse models of Alzheimer’s disease

  2023cites this paper
• Clinical evidence of human pathogens implicated in Alzheimer’s disease pathology and the therapeutic efficacy of antimicrobials: an overview

  2023cites this paper
• Adipose tissue as a therapeutic target for vascular damage in Alzheimer's disease

  2023cites this paper
• Genetic Reduction of Insulin Signaling Mitigates Amyloid-β Deposition by Promoting Expression of Extracellular Matrix Proteins in the Brain

  2023cites this paper
• Under the umbrella of depression and Alzheimer's disease physiopathology: can cannabinoids be a dual-pleiotropic therapy?

  2023cites this paper
• Anti-inflammatory effects of vagus nerve stimulation in pediatric patients with epilepsy

  2023cites this paper
• APOE4 impairs the microglial response in Alzheimer’s disease by inducing TGFβ-mediated checkpoints

  2023cites this paper
• Diverse signaling mechanisms and heterogeneity of astrocyte reactivity in Alzheimer's disease

  2023cites this paper
• TGF-β1 signalling in Alzheimer’s pathology and cytoskeletal reorganization: a specialized Tau perspective

  2023influential citation
• Co-Expression Network Analysis Identifies Molecular Determinants of Loneliness Associated with Neuropsychiatric and Neurodegenerative Diseases

  2023cites this paper
• Garden Cress (Lepidium sativum) Seeds Ameliorated Aluminum-Induced Alzheimer Disease in Rats Through Antioxidant, Anti-Inflammatory, and Antiapoptotic Effects.

  2023cites this paper
• Proteo-genomics of soluble TREM2 in cerebrospinal fluid provides novel insights and identifies novel modulators for Alzheimer’s disease

  2023cites this paper
• The relationship between TGF-β1 and cognitive function in the brain.

  2023cites this paper
• TGF-β as a Key Modulator of Astrocyte Reactivity: Disease Relevance and Therapeutic Implications

  2022influential citation
• The Effect of TGF-β1 Reduced Functionality on the Expression of Selected Synaptic Proteins and Electrophysiological Parameters: Implications of Changes Observed in Acute Hepatic Encephalopathy

  2022cites this paper
• Transfer of Tumor-Bearing Mice Intestinal Flora Can Ameliorate Cognition in Alzheimer’s Disease Mice

  2022cites this paper
• Extracellular microRNA and cognitive function in a prospective cohort of older men: The Veterans Affairs Normative Aging Study

  2022cites this paper
• Amyloidogenesis and Neurotrophic Dysfunction in Alzheimer’s Disease: Do They have a Common Regulating Pathway?

  2022cites this paper
• Specificity of TGF-β1 signal designated by LRRC33 and integrin αVβ8

  2022cites this paper
• The contribution of inflammation to Alzheimer's disease in Down syndrome

  2022cites this paper
• Artificial nerve graft constructed by coculture of activated Schwann cells and human hair keratin for repair of peripheral nerve defects

  2022cites this paper
• The role of transforming growth factor β1 /Smad pathway in Alzheimer’s disease inflammation pathology

  2022influential citation
• Small molecule C381 targets the lysosome to reduce inflammation and ameliorate disease in models of neurodegeneration

  2022cites this paper
• Plasma microRNAs as a Potential Biomarker for Identification of Progressive Supranuclear Palsy

  2022cites this paper
• Perivascular SPP1 Mediates Microglial Engulfment of Synapses in Alzheimer’s Disease Models

  2022cites this paper
• The road to precision medicine: Eliminating the "One Size Fits All" approach in Alzheimer's disease.

  2022cites this paper
• Small RNA Sequencing in the Tg4–42 Mouse Model Suggests the Involvement of snoRNAs in the Etiology of Alzheimer’s Disease

  2022cites this paper
• Microglia in Alzheimer’s Disease: a Key Player in the Transition Between Homeostasis and Pathogenesis

  2022cites this paper
• Characterization of Cortical Glial Scars in the Diisopropylfluorophosphate (DFP) Rat Model of Epilepsy

  2022cites this paper
• Phenazopyridine promotes RPS23RG1/Rps23rg1 transcription and ameliorates Alzheimer-associated phenotypes in mice

  2022cites this paper
• The transcriptomic landscape of neurons carrying PSEN1 mutations reveals changes in extracellular matrix components and non-coding gene expression.

  2022cites this paper
• Oncogenic Pathways in Neurodegenerative Diseases

  2022cites this paper
• Transcriptomic characterization of tissues from patients and subsequent pathway analyses reveal biological pathways that are implicated in spastic ataxia

  2022cites this paper
• Improving Cognition with Nutraceuticals Targeting TGF-β1 Signaling

  2021cites this paper
• Photobiomodulation-Activated Latent Transforming Growth Factor-β1: A Critical Clinical Therapeutic Pathway and an Endogenous Optogenetic Tool for Discovery

  2021cites this paper
• Biomarkers used in Alzheimer's Disease diagnosis, treatment, and prevention.

  2021cites this paper
• Single-cell transcriptomics identifies master regulators of neurodegeneration in SOD1 ALS iPSC-derived motor neurons

  2021cites this paper
• The effect of 4-Week rehabilitation by aerobic exercise on hippocampus BDNF and TGF-β1 gene expressions inAβ 1-42-induced rat model of Alzheimer's disease.

  2021cites this paper
• Dissecting the Crosstalk between Endothelial Mitochondrial Damage, Vascular Inflammation, and Neurodegeneration in Cerebral Amyloid Angiopathy and Alzheimer’s Disease

  2021cites this paper
• The Amyloid-β Pathway in Alzheimer’s Disease

  2021cites this paper
• Novel Discoveries in Immune Dysregulation in Inborn Errors of Immunity

  2021cites this paper
• APOE2, E3, and E4 differentially modulate cellular homeostasis, cholesterol metabolism, and inflammatory response in isogenic iPSC-derived astrocytes

  2021cites this paper
• Human-Soybean Allergies: Elucidation of the Seed Proteome and Comprehensive Protein-Protein Interaction Prediction.

  2021cites this paper
• Gene Expression Profile in Different Age Groups and Its Association with Cognitive Function in Healthy Malay Adults in Malaysia

  2021cites this paper
• Genes Associated with Amyloid-beta-induced Inflammasome-mediated Neuronal Death Identified Using Functional Gene Trap Mutagenesis Approach.

  2021cites this paper
• Targeting innate immunity to protect and cure Alzheimer’s disease: opportunities and pitfalls

  2021cites this paper
• Stem cell-based therapy as a promising approach in Alzheimer's disease: current perspectives on novel treatment

  2021cites this paper
• Caffeic acid protects against Aβ toxicity and prolongs lifespan in Caenorhabditis elegans models.

  2021cites this paper
• Neuroinflammation and its resolution in Alzheimer's disease

  2021cites this paper
• Could α-Klotho Unlock the Key Between Depression and Dementia in the Elderly: from Animal to Human Studies

  2021cites this paper
• Emerging roles of growth differentiation factor-15 in brain disorders (Review)

  2021cites this paper
• Sex differences in microglia as a risk factor for Alzheimer’s disease

  2021cites this paper
• Tetrahydrocurcumin ameliorates Alzheimer's pathological phenotypes by inhibition of microglial cell cycle arrest and apoptosis via Ras/ERK signaling.

  2021cites this paper
• A Path Toward Precision Medicine for Neuroinflammatory Mechanisms in Alzheimer's Disease

  2020cites this paper
• Paeoniflorin ameliorates antipsychotic-induced hyperprolactinemia in rats by attenuating impairment of the dopamine D2 receptor and TGF-β1 signaling pathways in the hypothalamus and pituitary.

  2020cites this paper
• Amyloid‐β oligomers in cellular models of Alzheimer’s disease

  2020cites this paper
• Fluid Candidate Biomarkers for Alzheimer’s Disease: A Precision Medicine Approach

  2020cites this paper
• Insulin resistance, diabetes, and metabolic syndrome

  2020cites this paper
• If ineffective levels of transforming growth factors and their receptor account for old age being a risk factor for Alzheimer's disease, then increasing TGFBR2 might be therapeutic

  2020cites this paper
• FAM3C in Alzheimer's disease

  2020cites this paper
• Cerebral amyloid accumulation is associated with distinct structural and functional alterations in the brain of depressed elders with mild cognitive impairment.

  2020cites this paper
• Integrated network pharmacology and zebrafish model to investigate dual-effects components of Cistanche tubulosa for treating both Osteoporosis and Alzheimer's Disease.

  2020cites this paper
• The immune system on the TRAIL of Alzheimer’s disease

  2020cites this paper